PerkinElmer Announces Strategic Acquisition of Arnel Inc.
News Mar 03, 2009
PerkinElmer, Inc. has announced the acquisition of Arnel Inc., a leader in custom engineered solutions for gas chromatography applications in the petrochemical, food and beverage, and industrial hygiene markets.
The acquisition is an important strategic initiative to expand PerkinElmer's chromatography portfolio and strengthen its application-focused expertise to best serve the biofuels and hydrocarbon processing industries.
This acquisition is a natural extension of PerkinElmer's and Arnel's 18 year relationship during which Arnel served as PerkinElmer's exclusive supplier of gas sampling valve solutions. With the completion of this transaction, PerkinElmer expects to accelerate its development and expand its portfolio of application-focused measurement systems tailored for the biofuels, food and beverage, industrial hygiene, and hydrocarbon processing markets.
"PerkinElmer has a deep understanding of our customers' specific industry related challenges, whether these customers are in the pharmaceutical, consumer, or food quality industries," notes Richard Begley, Ph.D., president, PerkinElmer Analytical Sciences.
"Our acquisition of Arnel brings us greater expertise in the hydrocarbon processing industry through differentiated technology in gas chromatography. In addition, we believe that combining Arnel's technologies with PerkinElmer's chromatography capabilities will help our customers develop cleaner, petroleum based products to help reduce their impact on the environment as well as assist in manufacturing more cost effective petroleum products," Dr. Begley added.
Through this acquisition, PerkinElmer continues its ability to provide standard and custom petroleum tailored solutions based upon PerkinElmer's gas chromatography platform. These analyzers include the widest range of refinery/light hydrocarbon gas analyzers (RGA) and natural gas analyzers (NGA) in the industry.
Elpis BioMed Closes Funding Round to Commercialise Novel Technology Platform for Generating Human Cell TypesNews
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types. Geographically diversified, top-tier investor team includes key industry leaders to support early company development.READ MORE
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE
BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences ProductsNews
BOC Sciences continues to add more publication items that used BOC Sciences products in their researches to its already existing collection.READ MORE